Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
33 hedge funds and large institutions have $34.3M invested in Histogen Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 12 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
22% more capital invested
Capital invested by funds: $28.1M → $34.3M (+$6.16M)
21% more call options, than puts
Call options by funds: $739K | Put options by funds: $610K
3% more funds holding
Funds holding: 32 → 33 (+1)
8% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 12
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
+$5.98M |
| 2 |
Jennison Associates
New York
|
+$3.84M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.19M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.67M |
| 5 |
IHM
Iguana Healthcare Management
New York
|
+$1.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.57M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.35M |
| 3 |
PP
PDT Partners
New York
|
-$680K |
| 4 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$498K |
| 5 |
SIM
Spark Investment Management
New York
|
-$369K |
HSTO Hedge Fund Activity: Q2 2015 in Review
33 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q2 2015, worth a combined $34.3M — up 22% from $28.1M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new HSTO positions and 12 closed out — a net gain of 1 holder — while 8 added to existing stakes and 5 trimmed.
The largest buyer was HealthCor Management, opening a new position worth an estimated $5.98M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $1.57M sold.
- 33 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q2 2015, up from 32 in Q1 2015.
- Funds reported $34.3M of Histogen Inc. Common Stock stock for Q2 2015, up 22% quarter-over-quarter.
- 13 funds opened new Histogen Inc. Common Stock positions in Q2 2015 and 12 closed out, a net change of +1 holder.
- The largest Histogen Inc. Common Stock buyer in Q2 2015 was HealthCor Management, an estimated $5.98M added.
- The largest Histogen Inc. Common Stock seller in Q2 2015 was Sphera Funds Management, an estimated $1.57M sold.
Based on aggregated 13F filings for Q2 2015.